Table 3.
Diagnostic performance of SNB for axillary staging in AUS-negative patients
| No. of patients | ||||
| Permanent histopathology | ||||
| Intraoperative frozen Histopathology | Total | Metastasis positive | Metastasis negative | |
| A. | Total (n = 124) | |||
| Metastasis positive | 24 | 24 | 0 | |
| Metastasis negative | 100 | 1 | 99 | |
| Total | 124 | 25 | 99 | |
| B. | 18F-FDG uptake positive (n = 12) | |||
| Metastasis positive | 5 | 5 | 0 | |
| Metastasis negative | 7 | 1 | 6 | |
| Total | 12 | 6 | 6 | |
| C. | 18F-FDG uptake negative (n = 112) | |||
| Metastasis positive | 19 | 19 | 0 | |
| Metastasis negative | 93 | 0 | 93 | |
| Total | 112 | 19 | 93 | |
Note; SNB, sentinel node biopsy; AUS, axillary ultrasound; No., Number; SNB identification rate 99.2% (124 of 125 cases)
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPN), and accuracy overall were 96, 100, 100, 99, and 99%, respectively in A. Sensitivity, specificity, PPV, NPV, and overall accuracy were 83, 100, 100, 86, and 92%, respectively in B.
Sensitivity, specificity, PPV, NPV, and overall accuracy were 100, 100, 100, 100, and 100%, respectively in C.